JPRN-UMIN000042918
Recruiting
未知
Prospective observational comparison study between endovascular treatment devices for femoropopliteal arterial disease - Toma-Code FP study
ConditionsPeripheral Arterial disease
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Peripheral Arterial disease
- Sponsor
- Kameda Medical Center
- Enrollment
- 600
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Subjects who rejected to participate this study through Opt\-out method applied by a poster 2\. Life expectancy \<12 months 3\. Pregnancy, suspected pregnancy, or breastfeeding during study period 4\. Presence of cerebrovascular accident or myocardial infarction within 1 month of procedure 5\. Untreated external iliac artery inflow lesion 6\. Acute occlusive intraluminal thrombosis of the proposed lesion site. 7\. Evidence of an aneurysm at the target lesion site
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
To compare the RIPASA and modified alvarado score in to diagnose acute appendicitis and find out a better scoring system, so that the negative appendectomy rates are decreased.Health Condition 1: K358- Other and unspecified acute appendicitisCTRI/2022/11/047668Kasturba Hospital, Manipal.
Not yet recruiting
Not Applicable
Study between outcome of open hemorrhoidectomy and stapler hemorrhoidopexy in Grade III and Grade IV hemorrhoidsCTRI/2023/07/054919Kmc manipal
Recruiting
Not Applicable
airway assessment to predict difficult endotracheal intubatioHealth Condition 1: O- Medical and SurgicalCTRI/2021/10/037057Government Institute of Medical sciences
Completed
Not Applicable
Comparison of blind versus USG guided spinal anaesthesia in elderly patients posted for truma surgeryCTRI/2017/11/010567Department of Anaesthesia60
Not yet recruiting
Not Applicable
A study to compare the patient reported outcomes with the use of oral dydrogesterone vs. micronized vaginal progesterone in high risk pregnanciesHealth Condition 1: O092- Supervision of pregnancy with other poor reproductive or obstetric historyCTRI/2022/11/047511Emcure Pharmaceuticals Ltd